LEADER 05162nam 22006974a 450 001 9910145283403321 005 20230617010515.0 010 $a1-281-32233-4 010 $a9786611322335 010 $a0-470-75141-X 010 $a0-470-75140-1 035 $a(CKB)1000000000399357 035 $a(EBL)351598 035 $a(OCoLC)437218821 035 $a(SSID)ssj0000238871 035 $a(PQKBManifestationID)11175354 035 $a(PQKBTitleCode)TC0000238871 035 $a(PQKBWorkID)10234483 035 $a(PQKB)10171266 035 $a(MiAaPQ)EBC351598 035 $a(Au-PeEL)EBL351598 035 $a(CaPaEBR)ebr10232730 035 $a(CaONFJC)MIL132233 035 $a(EXLCZ)991000000000399357 100 $a20040512d2004 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe road to successful CRT implantation$b[electronic resource] $ea step-by-step approach /$fDaniel Gras, Angel R. Leo?n, Westby G. Fisher ; foreword by William T. Abraham 210 $aMalden, Mass. $cBlackwell Futura$d2004 215 $a1 online resource (112 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-1718-4 320 $aIncludes bibliographical references and index. 327 $aThe Road to Successful CRT Implantation: A step-by-step approach; Contents; Dedication; Foreword; General remarks; 1 How does ventricular dyssynchrony alter hemodynamic function?; 2 What clinical benefits can we expect from CRT?; 3 How to select candidates for CRT; 4 Assessment of ventricular dyssynchrony by new echocardiographic analyses; 5 What are the mechanisms of improvement during CRT?; 6 Clinical situations where CRT is unlikely to be of therapeutic value; 7 Preimplantation checklist; 8 Right versus left-sided approach to implant the CRT system; 9 Right ventricular pacing in CRT 327 $a10 How to achieve reliable sensing and pacing of the right atrium 11 Is it safe to pace the left ventricle via a coronary sinus tributary?; 12 Why perform a coronary sinus venogram before placement of the left ventricular lead?; 13 Optimal LV lead positioning; 14 How to manage difficult coronary sinus cannulation; 15 How to avoid a dissection of the coronary sinus ostium; 16 How to overcome a myocardial bridge over the coronary sinus; 17 What to do in the absence of a lateral branch on the venogram; 18 How to manage high left ventricular pacing thresholds 327 $a19 How to proceed in the presence of a complex coronary sinus anatomy 20 How to manage diminutive target coronary sinus tributaries; 21 What to do when valves are in the way; 22 How to implant a CRT system in the presence of a left superior vena cava; 23 Dilatation of the target cardiac vein by angioplasty techniques; 24 Stenting for recurrent dislodgment of the left ventricular lead; 25 Assessment of the electrical signal sensed by the left ventricular lead; 26 How to avoid stimulating the left phrenic nerve; 27 Dye extravasation and venous perforation or dissection 327 $a28 How to avoid a cardiac vein dissection by the balloon catheter 29 How to remove the guiding sheath using the slitting technique; 30 Radiographic appearance of the final lead position of the CRT system; 31 How to implant a CRT device in patients with chronic atrial fibrillation; 32 Upgrading DDD pacing to CRT; 33 Upgrading a CRT to a CRT-ICD system; 34 Repositioning of a dislodged left ventricular lead; 35 How to implant a four-chamber CRT system; 36 How to implant a biventricular, double-left ventricular lead CRT system; 37 Alternatives in left ventricular lead implant failures 327 $a38 Left ventricular lead extraction 39 Management of ventricular double counting in CRT; 40 Management of non-responders to CRT; References; Index 330 $aCardiac resynchronization therapy is a new therapy for advanced heart failure patients. This therapy has been shown to improve quality of life, exercise capacity, NYHA classification, and even reverse the detrimental ""reverse remodeling"" that occurs in advanced heart failure - in patients already receiving optimal pharmacological therapy. The typical patient has NYHA III/IV HF symptoms, a QRS > 120 ms, LVEDD > 55 mm, without any indication required for pacing. The therapy is available in an ICD device, too. CRT has been shown to be effective in patients with both ischemic and non-ische 606 $aImplantable cardioverter-defibrillators 606 $aCardiac pacing 606 $aHeart failure$xSurgery 606 $aCardiovascular instruments, Implanted 615 0$aImplantable cardioverter-defibrillators. 615 0$aCardiac pacing. 615 0$aHeart failure$xSurgery. 615 0$aCardiovascular instruments, Implanted. 676 $a617.4/120592 700 $aGras$b Daniel$0937325 701 $aLeo?n$b Angel R$0937326 701 $aFisher$b Westby G$0937327 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910145283403321 996 $aThe road to successful CRT implantation$92111376 997 $aUNINA LEADER 05443nam 2200697 a 450 001 996213961203316 005 20230721030838.0 010 $a1-281-32031-5 010 $a9786611320317 010 $a0-470-98889-4 010 $a0-470-99429-0 035 $a(CKB)1000000000404552 035 $a(EBL)350937 035 $a(OCoLC)808684187 035 $a(SSID)ssj0000192344 035 $a(PQKBManifestationID)11166236 035 $a(PQKBTitleCode)TC0000192344 035 $a(PQKBWorkID)10187455 035 $a(PQKB)11093926 035 $a(MiAaPQ)EBC350937 035 $a(EXLCZ)991000000000404552 100 $a20060724d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aLight and plant development$b[electronic resource] /$fedited by Garry C. Whitelam and Karen J. Halliday 210 $aOxford ;$aAmes, Iowa $cBlackwell Pub.$d2007 215 $a1 online resource (350 p.) 225 1 $aAnnual plant reviews ;$vv. 30 300 $aDescription based upon print version of record. 311 $a1-4051-4538-2 320 $aIncludes bibliographical references and index. 327 $aLight and Plant Development; Contents; Contributors; Preface; Part I Photoreceptors; 1 Phytochromes; 1.1 Introduction; 1.2 Historical aspects; 1.3 Properties of phyA in vivo; 1.4 Properties in yeast cells; 1.5 In vivo properties of phytochromes; 1.5.1 In vivo spectroscopy; 1.6 Intracellular localisation of phytochromes; 1.6.1 Classical methods; 1.6.2 Spectroscopic methods; 1.6.3 Cell biological methods; 1.6.4 Immunocytochemical methods; 1.6.5 Novel methods; 1.7 Intracellular localisation of phyB in dark and light; 1.8 Intracellular localisation of phyA in dark and light 327 $a1.9 Intracellular localisation of phyC, phyD and phyE in dark and light1.10 Phytochrome/PIF3 co-localisation and nuclear speckles; 1.11 Regulation of intracellular localisation of phytochromes; Acknowledgements; References; 2 Cryptochromes; 2.1 Introduction; 2.2 Cryptochrome genes and their evolution; 2.3 Cryptochrome domains, chromophores and structure; 2.3.1 Domain structure of the cryptochromes; 2.3.2 Cryptochrome chromophores; 2.3.3 Photolyase and cryptochrome structure; 2.3.3.1 Photolyase structure and reaction mechanism; 2.3.3.2 Cryptochrome structure 327 $a2.4 Cryptochrome biochemistry and spectroscopy2.4.1 Phosphorylation; 2.4.2 Nucleotide-binding and kinase activity; 2.4.3 DNA-binding activity; 2.4.4 Electron transfer; 2.5 Expression and biological activity of cryptochromes; 2.5.1 Expression and light regulation of cryptochromes in planta; 2.5.2 Cellular localization; 2.5.3 Growth responses controlled by cryptochromes; 2.5.4 Regulation of gene expression through cryptochromes; 2.6 Cryptochrome signalling; 2.6.1 Dimerization and output domains; 2.6.2 Cryptochrome partners; 2.6.2.1 Interaction with COP1 327 $a2.6.2.2 Interaction with zeitlupe/ADAGIO12.6.2.3 Interaction with phytochromes; 2.6.3 Further downstream components; 2.7 Summary; Acknowledgements; References; 3 Phototropins and other LOV-containing proteins; 3.1 Introduction; 3.2 Phototropins and their biological functions; 3.2.1 Physiological roles in higher plants; 3.2.2 Physiological roles in lower plants; 3.3 Phototropin structure, localization and activity; 3.3.1 Phototropin structure and localization; 3.3.2 Phototropin autophosphorylation; 3.4 Light sensing by the LOV domains; 3.4.1 LOV-domain photochemistry 327 $a3.4.2 LOV-domain structure3.4.3 Functional roles of LOV1 and LOV2; 3.4.4 Light-induced protein movements; 3.5 Phototropin signaling; 3.5.1 Phototropin-interacting proteins; 3.5.2 Downstream signaling targets; 3.6 Other LOV-containing proteins; 3.6.1 LOV-containing proteins in Arabidopsis; 3.6.2 LOV-containing proteins in fungi; 3.6.3 LOV-containing proteins in bacteria; 3.7 Conclusions and future perspectives; Acknowledgements; References; Part II Photoreceptor signal transduction; 4 Phytochrome-interacting factors; 4.1 Introduction; 4.2 Methodology; 4.2.1 Initial identification of PIFs 327 $a4.2.2 Subsequent assay and characterization of the interaction 330 $aLiving organisms are subject to fluctuating environmental conditions. Whereas most animals are able to move away from unfavourable conditions, plants are sessile and so must cope with whatever comes their way. Of all the environmental cues that challenge the developing plant, light can probably be considered to be the most important. In addition to its key role in plant metabolism, and hence almost all life on Earth, where it drives the process of photosynthesis, light energy also acts to regulate plant growth and development. Light quantity, quality, direction and diurnal and seasonal duratio 410 0$aAnnual plant reviews ;$vv. 30. 606 $aPhytochrome 606 $aPlants$xPhotomorphogenesis 606 $aPlants$xDevelopment 615 0$aPhytochrome. 615 0$aPlants$xPhotomorphogenesis. 615 0$aPlants$xDevelopment. 676 $a571.8/2 676 $a572.46 676 $a580.5 686 $a42.42$2bcl 701 $aWhitelam$b Garry C$0924368 701 $aHalliday$b Karen J$0924369 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996213961203316 996 $aLight and plant development$92074364 997 $aUNISA LEADER 01607oam 2200409 450 001 9910717493203321 005 20211119130415.0 035 $a(CKB)4330000001257942 035 $a(OCoLC)925473395 035 $a(EXLCZ)994330000001257942 100 $a20151019d2005 ua 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aComparison of codes, standards, and practices in use at the time of the design and construction of World Trade Center 1, 2, and 7 /$fJoseph C. Razza, Raymond A. Grill 210 1$a[Gaithersburg, MD] :$cNational Institute of Standards and Technology, Technology Administration, U.S. Department of Commerce,$d2005. 215 $a1 online resource (xxvi, 72 pages) $ccolor illustration 225 1 $aNIST NCSTAR ;$v1-1 E 300 $a"September 2005." 320 $aIncludes bibliographical references (page 7). 606 $aTall buildings$zUnited States$xDesign and construction 606 $aBuilding laws$zNew York (State)$zNew York 615 0$aTall buildings$xDesign and construction. 615 0$aBuilding laws 700 $aRazza$b Joseph C.$01409717 702 $aGrill$b Raymond A. 712 02$aNational Institute of Standards and Technology (U.S.), 801 0$bNBS 801 1$bNBS 801 2$bOCLCO 801 2$bOCLCQ 906 $aBOOK 912 $a9910717493203321 996 $aComparison of codes, standards, and practices in use at the time of the design and construction of World Trade Center 1, 2, and 7$93529218 997 $aUNINA